Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor

Arthritis and Rheumatism

Volumn 48, Issue 1, 2003, Pages 103-109

  Lacey, Derek ^a   Sampey, Annaleise ^a   Mitchell, Robert ^b   Bucala, Richard ^b   Santos, Lanie ^a   Leech, Michelle ^a   Morand, Eric ^a  

^a MONASH UNIVERSITY   (Australia)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JOINT DESTRUCTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

EID: 0037236049     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10733     Document Type: Article

References (41)

1. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MBB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989;83:1267-76.
2. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: results of proliferating cell nuclear antigen/cyclin, c-Myc, and nucleolar organizer region staining. Arthritis Rheum 1994;37:212-20.
3. Zvaifler NJ, Firestein GS. Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 1994;37:783-9.
4. Inoue H, Takamori M, Nagata N, Nishikawa T, Oda H, Yamamoto S, et al. An investigation of cell proliferation and soluble mediators induced by interleukin 1β in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inflamm Res 2001;50:65-72.
5. Foxwell B, Browne K, Bondeson J, Clarke C, Demartin R, Brennan F. Efficient adenoviral infection with I-κ-B-α reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κ-B dependent. Proc Natl Acad Sci U S A 1998;95: 8211-5.
6. Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000;43:2501-12.
7. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-902.
8. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A 1998;95:11383-8.
9. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Molecular Medicine 1999;5:181-91.
10. Leech M, Metz CN, Smith M, Weedon H, Holdsworth SR, Bucala R, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence for proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999;42:1601-8.
11. 2 and cyclooxygenase-2 by macrophage migration inhibitory factor. Arthritis Rheum 2001;44:1273-80.
12. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158:5514-7.
13. Leech M, Metz CN, Santos LL, Peng T, Holdsworth SR, Bucala R, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998;41:910-7.
14. Santos LL, Hall P, Metz CN, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001;123:309-14.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-55.
17. Pettit AR, Quinn C, Macdonald KP, Cavanagh LI, Thomas G, Townsend W, et al. Nuclear localization of Relb is associated with effective antigen presenting cell function. J Immunol 1997;159:3681-91.
18. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor nuclear factor κB in human synovial cells in response to tumor necrosis factor a. Arthritis Rheum 1996;39:197-203.
19. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995;270:14255-8.
20. Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor: regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999;274:18100-6.
21. Joosten LA, Helsen MM, Saxne T, Van De Loo FA, Heinegard D, Van Den Berg WB. IL-1α/β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-55.
22. Campbell IK, O'Donnell K, Lawlor KE, Wicks IP. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 2001;107:1519-27.
23. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-9.
24. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
25. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277-82.
26. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7849-54.
27. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999;11:163-7.
28. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50.
29. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
30. Morita Y, Kashihara N, Yamamura M, Okamoto H, Harada S, Kawashima M. Antisense oligonucleotides targeting c-Fos mRNA inhibit rheumatoid synovial fibroblast proliferation. Ann Rheum Dis 1998;57:122-4.
31. Aupperle KR, Bennett BL, Boyle DL, Tak PP, Manning AM, Firestein GS. NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes. J Immunol 1999;163:427-33.
32. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, et al. Involvement of macrophage migration inhibitory factor in the mechanism of tumor cell growth. Molecular Medicine 1998;4: 707-14.
33. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-82.
34. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-6.
35. Taki H, Sugiyama E, Kuroda A, Mino T, Harada S, Kobayashi M. p38 MAP kinase is activated in rheumatoid synovium: involvement of p38 MAP kinase pathway for IL-1- and TNFα-stimulated IL-6 and IL-11 production by rheumatoid synoviocytes [abstract]. Arthritis Rheum 1998;41 Suppl 9:S39.
36. Badger AM, Griswold DE, Kapadia R, Blake S, Swift BA, Hoffman SJ, et al. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:175-83.
37. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001;108:73-81.
38. Barchowsky A, Frleta D, Vincenti MP. Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 2000; 12:1469-79.
39. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, et al. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998;273:3285-90.
40. Bennett BL, Aupperle KR, Manning AM, Firestein GS. Activation of IκB kinase (IKK) in fibroblast-like synoviocytes (FLS) [abstract]. Arthritis Rheum 1998;41 Suppl 9:S351.
41. Daun JM, Cannon JG. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am J Physiol 2000;279:R1043-9.